Filter
838
Filtered Results: 838
Text search:
mutation
Featured
Recommendations
111
New Publications
169
Language
Document type
No document type
376
Guidelines
175
Studies & Reports
141
Manuals
39
Fact sheets
39
Strategic & Response Plan
32
Training Material
16
Situation Updates
7
Videos
4
Resource Platforms
3
Infographics
3
Brochures
2
App
1
Countries / Regions
India
39
Global
31
Western and Central Europe
21
Africa
20
Latin America and the Carribbean
20
South Africa
19
Germany
17
Senegal
15
Ethiopia
13
Colombia
12
Burkina Faso
11
Kenya
10
Cameroon
10
Benin
9
Nigeria
9
Congo, Democratic Republic of
8
Zambia
8
Tanzania
7
Eastern Europe
7
Nepal
6
Malawi
6
Haiti
6
Paraguay
6
Liberia
6
Rwanda
5
Asia
5
Russia
5
Ukraine
4
El Salvador
4
Syria
4
Guinea
4
Venezuela
4
East and Southern Africa
4
Bolivia
4
Uganda
4
Brazil
4
Mali
4
Eswatini/ Swaziland
4
Ghana
3
Sierra Leone
3
Peru
3
Philippines
3
Mozambique
3
Cambodia
3
Middle East and North Africa
3
Argentina
3
Bangladesh
3
Namibia
3
Ecuador
3
Madagascar
3
Thailand
2
Mexico
2
Niger
2
Zimbabwe
2
Morocco
2
West and Central Africa
2
South–East Asia Region
2
Uruguay
2
France
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Central African Republic
2
Chad
2
Libya
2
Indonesia
2
Iraq
2
Somalia
2
Myanmar / Burma
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Togo
1
China
1
Kazakhstan
1
Chile
1
Iran
1
Congo-Brazzaville
1
Qatar
1
Mauritania
1
USA
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Jamaica
1
Tunisia
1
Belarus
1
Israel
1
Southern Africa
1
Vietnam
1
Nicaragua
1
Egypt
1
Sudan
1
Yemen
1
Palestine
1
Honduras
1
Botswana
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
270
Clinical Guidelines
116
Public Health
41
Pharmacy & Technologies
24
Key Resources
17
Women & Child Health
16
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
COVID-19
146
TB
129
HIV
74
AMR
45
Mental Health
32
Rapid Response
30
Pharmacy
24
NTDs
20
Planetary Health
18
NCDs
17
Ebola
14
Refugee
13
Caregiver
9
Disability
6
Conflict
6
Polio
6
Zika
5
Specific Hazards
4
Health Financing Toolbox
4
Global Health Education
3
Natural Hazards
2
Social Ethics
2
The purpose of this document is to offer guidance to Member States on quarantine measures for individuals in the context of COVID-19. It is intended for those responsible for establishing local or national policy for quarantine of individuals, and adherence to infection prevention and control measur...
14 July 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
COVID-19 vaccines have proven to be safe, ...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Nature | Vol 600 | 2 December 2021 |
Update on SARS-CoV-2 variant of concern Omicron
recommended
Update 70, 10 Dec. 2021
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that policies can be tailored to different population groups. ...
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
Available in English, French and Spanish
Available in English, French and Spanish
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
The arrival and rapid spread of the mosquito-borne viral disease Chikungunya across the Americas is one of the most significant public health developments of recent years, preceding and mirroring the subsequent spread of Zika. Globalization in trade and travel can lead to the importation of these vi...
As the world recovers from the shock of the COVID-19 pandemic and reflects on lessons learnt from failure of global public health systems to contain the global outbreak of SARS-CoV-2, new infectious disease threats, caused by movement of people globally, remain omnipresent, and repeated calls for mo...
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
